ISIN | IE00BXDZNH00 |
---|---|
Valor Number | 29317245 |
Bloomberg Global ID | UPVLH SW |
Fund Name | UBS (Irl) ETF plc - UBS Factor MSCI USA Prime Value Screened UCITS ETF hGBP dis |
Fund Provider | UBS Asset Management (UK) Ltd |
Fund Provider | UBS Asset Management (UK) Ltd |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity United States |
Distribution Policy | Distribution |
Home Country | Ireland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The objective of the Fund is to seek to track the alternatively weighted equity market performance of the US market. The investment policy of the Fund is to seek to track the performance of the MSCI USA Prime Value ESG Low Carbon Select Index (Net Return) (or any other index determined by the Directors from time to time to track substantially the same market as the MSCI USA Prime Value ESG Low Carbon Select Index (Net Return) and which is considered by the Directors to be an appropriate index for the Fund to track), in accordance with the Prospectus (the "Index") as closely as possible, while seeking to minimise as far as possible the difference in performance between the Fund and the Index. |
Peculiarities |
Current Price * | 17.63 GBP | 17.10.2025 |
---|---|---|
Previous Price * | 17.56 GBP | 16.10.2025 |
52 Week High * | 17.90 GBP | 06.10.2025 |
52 Week Low * | 14.59 GBP | 08.04.2025 |
NAV * | 17.63 GBP | 17.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 111,254,339 | |
Unit/Share Assets *** | 3,677,700 | |
Trading Information SIX |
YTD Performance | +7.75% |
31.12.2024 - 17.10.2025
31.12.2024 17.10.2025 |
---|---|---|
YTD Performance (in CHF) | +1.09% |
31.12.2024 - 17.10.2025
31.12.2024 17.10.2025 |
1 month | +1.25% |
17.09.2025 - 17.10.2025
17.09.2025 17.10.2025 |
3 months | +3.73% |
17.07.2025 - 17.10.2025
17.07.2025 17.10.2025 |
6 months | +15.27% |
17.04.2025 - 17.10.2025
17.04.2025 17.10.2025 |
1 year | +0.88% |
17.10.2024 - 17.10.2025
17.10.2024 17.10.2025 |
2 years | +27.30% |
17.10.2023 - 17.10.2025
17.10.2023 17.10.2025 |
3 years | +40.66% |
17.10.2022 - 17.10.2025
17.10.2022 17.10.2025 |
5 years | +70.29% |
19.10.2020 - 17.10.2025
19.10.2020 17.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Lam Research Corp | 3.34% | |
---|---|---|
Caterpillar Inc | 3.28% | |
Applied Materials Inc | 2.92% | |
Berkshire Hathaway Inc Class B | 2.82% | |
UnitedHealth Group Inc | 2.80% | |
Cisco Systems Inc | 2.58% | |
Merck & Co Inc | 2.55% | |
American Express Co | 2.47% | |
The Walt Disney Co | 2.29% | |
Texas Instruments Inc | 2.11% | |
Last data update | 13.10.2025 |
TER | 0.28% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.28% |
Ongoing Charges *** | 0.28% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |